Biocompatibility study of two diblock copolymeric nanoparticles for biomedical applications by in vitro toxicity testing

Journal of Nanoparticle Research

Volumn 15, Issue 11, 2013, Pages

  Goñi de Cerio, Felipe ^a   Mariani, Valentina ^b   Cohen, Dror ^c,d   Madi, Lea ^e   Thevenot, Julie ^f,g   Oliveira, Hugo ^f,g   Uboldi, Chiara ^b   Giudetti, Guido ^b   Coradeghini, Rosella ^b   Garanger, Elisabeth ^f,g   Rossi, François ^b   Portugal Cohen, Meital ^c   Oron, Miriam ^c   Korenstein, Rafi ^e   Lecommandoux, Sébastien ^f,g   Ponti, Jessica ^b   Suárez Merino, Blanca ^a   Heredia, Pedro ^a  

^a Centro Tecnologico Gaiker   (Spain)

^b JOINT RESEARCH CENTRE   (Italy)

^c AHAVA   (Israel)

^d Tamar Regional Council   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

^f UNIVERSITÉ DE BORDEAUX   (France)

^g UNIVERSITÉ BORDEAUX 1   (France)

Author keywords

Amphiphilic copolymers; Biomedicine; Cancer therapy; In vitro toxicity; Nanoparticles; Nanoparticles toxicity

Indexed keywords

AMPHIPHILIC CO-POLYMERS; BIOMEDICAL APPLICATIONS; BIOMEDICINE; BLOCK-COPOLYMER NANOPARTICLES; CANCER THERAPY; IN-VITRO; POLY (TRIMETHYLENE CARBONATE); REACTIVE OXYGEN SPECIES;

AMINO ACIDS; BIOCOMPATIBILITY; BIODEGRADATION; CELL CULTURE; CELL DEATH; CHEMOTHERAPY; COPOLYMERS; MEDICAL APPLICATIONS; NANOPARTICLES; POLYETHYLENE OXIDES; POLYPEPTIDES; TOXICITY;

POLYETHYLENE GLYCOLS;

COPOLYMER; INTERLEUKIN 1; NANOPARTICLE; PLASMA PROTEIN; POLY(ETHYLENE GLYCOL)BLOCK POLY(GAMMA BENZYL L GLUTAMATE); POLY(TRIMETHYLENE CARBONATE) BLOCK POLY(L GLUTAMIC ACID); POLYGLUTAMIC ACID; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ABSENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NECROSIS; NONHUMAN; ORGAN CULTURE; OXIDATIVE STRESS; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN INTERACTION; SKIN CULTURE; TOXICITY TESTING; ULTRAVIOLET B RADIATION;

EID: 84892639710     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-013-2036-0     Document Type: Article

References (52)

1. Ai J, Biazar E, Jafarpour M, Montazeri M, Majdi A, Aminifard S, Zafari M, Akbari HR, Rad HG (2011) Nanotoxicology and nanoparticle safety in biomedical designs. Int J Nanomed 6:1117-1127
2. Arimura H, Ohya Y, Ouchi T (2005) Formation of core-shell type biodegradable polymeric micelles from amphiphilic poly(aspartic acid)-block-polylactide diblock copolymer. Biomacromolecules 6(2):720-725
3. Backand S, Winder C, Hayes A (2011) Cell viability and cytokine production of human alveolar epithelial cells following exposure to sulphur dioxide. Int J Occup Hyg 3:63-69
4. Buzea C, Pacheco-Blandino II, Robbie K (2007) Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2:MR17-MR172
5. Carlsen A, Lecommandoux S (2009) Self-assembly of poly-peptide-based block copolymer amphiphiles. Curr Opin Colloid Interface Sci 14(5):329-339
6. Chen Y, Wan Y, Wang Y, Zhang H, Jiao Z (2011) Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide NPs. Int J Nanomed 6:2321-2326
7. Chiellini EE, Chiellini F, Solaro R (2006) Bioerodible polymeric NPs for targeted delivery of proteic drugs. J Nanosci Nanotechnol 6(9-10):3040-3047
8. Chiellini F, Bartoli C, Dinucci D, Piras AM, Anderson R, Croucher T (2007) Bioeliminable polymeric NPs for proteic drug delivery. Int J Pharm 343(1-2):90-97
9. Curtis J, Greenberg M, Kester J, Phillips S, Krieger G (2006) Nanotechnology and nanotoxicology: a primer for clinicians. Toxicol Sci 25(4):245-260
10. Dinarello CA (2000) Proinflammatory cytokines. Chest 118:503-508
11. Dong AJ, Deng LD, Sun DX, Zhang YT, Jin JZ, Yuan YJ (2004) Studies on paclitaxel-loaded NPs of amphiphilic block copolymer. Yao Xue Xue Bao 39(2):149-152
12. Duncan R, Ringsdorf H, Satchi-Fainaro R (2006) Polymer therapeutics I. In: Advances in polymer science. Springer, Berlin, pp 1-8
13. Geiser M, Kreyling WG (2010) Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol 7(2). doi:10.1186/1743-8977-7-2
14. Guo W, Huang N, Cai J, Xie W, Hamilton JA (2006) Fatty acid transport and metabolism in HepG2 cells. Am J Physiol Gastrointest Liver Physiol 290:528-534
15. Jeong YI, Nah JW, Lee HC, Kim SH, Cho CS (1999) Adriamycin release from flower-type polymeric micelle based on star-block copolymer composed of poly(gamma-benzyl L-glutamate) as the hydrophobic part and poly(ethylene oxide) as the hydrophilic part. Int J Pharm 188(1):49-58
16. Jeong YI, Kang MK, Sun HS, Kang SS, Kim HW, Moon KS, Lee KJ, Kim SH, Jung S (2004) All-trans-retinoic acid release from core-shell type NPs of poly(epsilon-caprolactone)/ poly(ethylene glycol) diblock copolymer. Int J Pharm 273(1-2):95-107
17. Jeong YI, Seo SJ, Park IK, Lee HC, Kang IC, Akaike T, Cho CS (2005) Cellular recognition of paclitaxel-loaded polymeric NPs composed of poly(gamma-benzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. Int J Pharm 296(1-2):151-161
18. Kricheldorf H (2006) Polypeptides and 100 years of chemistry of alpha-amino acid N-carboxyanhydrides. Angew Chem Int Ed Engl 45(35):5752-5784
19. Lankelma J, Dekker H, Luque FR, Luykx S, Hoekman K, Van der Valk P (1999) Doxorubicin gradients in human breast cancer. Clin Cancer Res 5:1703-1707
20. Lanone S, Boczkowski J (2006) Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Curr Mol Med 6(6):651-663
21. Li C (2002) Poly(L-glutamic acid)-anticancer drug conjugates. Adv Drug Deliv Rev 54(5):695-713
22. Li S, Wang A, Jiang W, Guan Z (2008) Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded NPs. BMC Cancer 8:103-111
23. Li X, Wang L, Fan Y, Feng Q, Cui F (2012) Biocompatibility and toxicity of NPs and nanotubes. J Nanomater 2012, Article ID 548389. doi:10.1155/2012/ 548389
24. Mandal D, Chatterjee U (2007) Synthesis and spectroscopy of CdS NPs in amphiphilic diblock copolymer micelles. J Chem Phys 126(13):13450-13457
25. Martinez Barbosa ME, Montembault V, Cammas-Marion S, Ponchel G, Fontaine L (2007) Synthesis and characterization of novel poly(γ-benzyl-L- glutamate) derivatives tailored for the preparation of NPs of pharmaceutical interest. Polym Int 56:317-324
26. Matsuzawa A, Saegusa K, Noguchi T, Sadamitsu C, Nishitoh H, Nagai S, Koyasu S, Matsumoto K, Takeda K, Ichijo H (2005) ROS dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol 6:587-592
27. Medina C, Santos-Martinez MJ, Radomski A (2007) Nanoparticles: pharmacological and toxicological significance. Br J Pharmacol 150:552-558
28. Monteiro-Riviere NA, Inman AO, Zhang LW (2009) Limitations and relative utility of screening assays to assess engineered NP toxicity in a human cell line. Toxicol Appl Pharmacol 234:222-235
29. Nishiyama N, Kataoka K (2006) Polymer therapeutics II. In: Advances in polymer science. Springer, Berlin, pp 67-101
30. Oberdörster G (2000) Toxicology of ultrafine particles: in vivo studies. Philos Trans R Soc Lond A 358:2719-2740
31. Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113(7):823-839
32. Oh I, Lee K, Kwon HY, Lee YB, Shin SC, Cho CS, Kim CK (1999) Release of adriamycin from poly(gamma-benzyl-Lglutamate)/poly(ethylene oxide) NPs. Int J Pharm 181(1): 107-115
33. Ponti J, Colognato R, Rauscher H, Gioria S, Broggi F, Franchin F, Pascual C, Giudetti G, Rossi F (2010) Colony forming efficiency and microscopy analysis of multi-wall carbon nanotubes cell interaction. Toxicol Lett 197:29-37
34. Portugal-Cohen M, Soroka Y, Frušić-Zlotkin M, Verkhovsky L, Brégégère FM, Neuman R, Kohen R, Milner Y (2011) Skin organ culture as a model to study oxidative stress, inflammation and structural alterations associated with UVB-induced photodamage. Exp Dermatol 20(9):749-755
35. Raab C, Simkó M, Gazsó A, Fiedeler U, Nentwich M (2008) Was sind synthetische Nanopartikel?. NanoTrust-Dossiers Nr. 002, hg. v. Institut für Technikfolgen-Abschätzung, Wien
36. Revell PA (2006) The biological effects of nanoparticles. Nanotechnol Percept 2:283-298
37. Sanson C, Schatz C, Le Meins JF, Brulet A, Soum A, Lecommandoux S (2010a) Biocompatible and biodegradable poly(trimethylene carbonate)-b-poly(L-glutamic acid) polymersomes: size control and stability. Langmuir 26(4): 2751-2760
38. Sanson C, Schatz C, Le Meins JF, Soum A, Thévenot J, Garanger E, Lecommandoux S (2010b) A simple method to achieve high doxorubicin loading in biodegradable polymersomes. J Control Release 147:428-435
39. Sanson C, Diou O, Thevenot J, Ibarboure E, Soum A, Brûlet A, Miraux S, Thiaudière E, Tan S, Brisson A, Dupuis V, Sandre O, Lecommandoux S (2011) Doxorubicin loaded magnetic polymersomes: theranostic nanocarriers for MR imaging and magneto-chemotherapy. ACS Nano 5:1122-1140
40. Satchi-Fainaro R, Duncan R, Barnes C (2006) Polymer therapeutics II. In: Advances in polymer science. Springer, Berlin, pp 1-65
41. Schanen BC, Karakoti AS, Seal S, Drake DR, Warren WL, Self WT (2009) Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct. ACS Nano 3:2523-2532
42. Sioutas C, Delfino RJ, Singh M(2005) Exposure assessment for atmospheric ultrafine particles (UFPs) and implications in epidemiologic research. Environ Health Perspect 113(8): 947-955
43. Stone V, Tuinman M, Vamvakopoulos JE, Shaw J, Brown D, Petterson S, Faux SP, Borm P, MacNee W, Michaelangeli F, Donaldson K (2000) Increased calcium influx in a monocytic cell line on exposure to ultrafine carbon black. Eur Respir J 15(2):297-303
44. Svobodova A, Walterova D, Vostalova J (2006) Ultraviolet light induced alteration to the skin. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150(1):25-38
45. Tang H, Guo J, Sun Y, Chang B, Ren Q, Yang W (2011) Facile synthesis of pH sensitive polymer-coated mesoporous silica NPs and their application in drug delivery. Int J Pharm 421:388-396
46. Tian F, Cui D, Schwarz H, Estrada GG, Kobayashi H (2006) Cytotoxicity of single-wall carbon nanotubes on human fibroblasts. Toxicol In Vitro 20:1202-1212
47. Tomoda K, Watanabe A, Suzuki K, Inagi T, Terada H, Makino K (2012) Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis. Colloids Surf B 97:84-89
48. Upadhyay KK, Agrawal HG, Upadhyay C, Schatz C, Le Meins JF, Misra A, Lecommandoux S (2009) Role of block copolymer nanoconstructs in cancer therapy. Crit Rev Ther Drug Carr Syst 26(2):157-205
49. Vega-Villa KR, Takemoto JK, Yáñez JA, Remsberg CM, Forrest ML, Davies NM (2008) Clinical toxicities of nanocarrier systems. Adv Drug Deliv Rev 60:929-938
50. Yang Y, Qu Y, Lü X (2010) Global gene expression analysis of the effects of gold NPs on human dermal fibroblasts. J Biomed Nanotechnol 6:234-246
51. Yost GS, Veranth JM, Reilly CA, Veronesi B (2006) Chapter 8: vanilloid receptors in the respiratory tract. In: Gardner DE (ed) Toxicology of the lung, 4th edn. Taylor and Francis Group, Boca Raton, pp 297-350
52. Zhang LW, Zeng L, Barron AR, Monteiro-Riviere NA (2007) Biological interactions of functionalized single-wall carbon nanotubes in human epidermal keratinocytes. Int J Toxicol 26:103-113